| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/21/2006 | US7001900 Central nervous system disorders |
| 02/21/2006 | US7001898 Treating conditions involving increased vascular resistance and cardiac insufficiency. |
| 02/21/2006 | US7001729 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 02/21/2006 | US7001607 polyaphron gel containing water-soluble fluorinated surfactant, water, and a nonpolar component, in particular, a fluorocarbon or a silicone oil; introducing gel into conjunctival sac of the eye |
| 02/21/2006 | CA2395196C Cyclic amp-specific phosphodiesterase inhibitors |
| 02/21/2006 | CA2193543C Sodium hyaluronate based ophthalmic formulation for use in eye surgery |
| 02/16/2006 | WO2006017614A1 Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 02/16/2006 | WO2006016582A1 Liquid culture method for inonotus obliquns |
| 02/16/2006 | WO2006016530A1 Transnasal composition having immediate action and high absorbability |
| 02/16/2006 | US20060036220 Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060035948 e.g. 6-nitro-4-[N-(4-chlorophenyl)-N-(2-methyl-2H-tetrazol-5-ylmethyl)amino]-3-hydroxy-2-methyl-2-dimethoxymethyl-3,4-dihydro-2H-1-benzopyran; protecting neuronal cells from oxidative stress induced cell death by iron or by hydrogen peroxide; antihypoxic agent, neuroprotectant |
| 02/16/2006 | US20060035916 2,4-Pyrimidinediamine compounds and their uses |
| 02/16/2006 | US20060035878 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 02/16/2006 | US20060035873 Methods for inducing apolipoprotein e secretion |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035868 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree) |
| 02/16/2006 | US20060035842 Ophthalmic composition |
| 02/16/2006 | US20060035811 Methods of treating dry eye disease with lantibiotics |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060034928 Tablet comprising cetirizine and pseudoephedrine |
| 02/16/2006 | US20060034892 Composition for topical administration |
| 02/16/2006 | US20060034822 Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vitreous body of the eye |
| 02/16/2006 | US20060034799 Tissue protective cytokines for the protection, restoration, and enhancement fo responsive cells, tissues and organs |
| 02/16/2006 | CA2576153A1 Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 02/16/2006 | CA2573668A1 Ophthalmic compositions and methods for treating ophthalmic conditions |
| 02/15/2006 | EP1626096A2 In vitro method of detecting a cell proliferative disorder involving fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/15/2006 | EP1625847A1 Pharmaceutical composition comprising a tetrahydrotriazolo[4,3-a]pyrazine |
| 02/15/2006 | EP1625165A2 Inhibitors of integrin alpha5beta1 and their use for the control of tissue granulation |
| 02/15/2006 | EP1624879A2 Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage |
| 02/15/2006 | EP1624758A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 02/15/2006 | EP1487456B1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
| 02/15/2006 | EP1341533B1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 02/15/2006 | EP1154767B1 Substituted stilbene compounds with vascular damaging activity |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1735400A Drug delivery system using subconjunctival depot |
| 02/15/2006 | CN1733704A Synthesis and biological and pharmacological action of betaine salicylate |
| 02/15/2006 | CN1733307A Antihypertensive combination of valsartan and calcium channel blocker |
| 02/15/2006 | CN1732979A Medicine for treating animal eyeball turbidness |
| 02/15/2006 | CN1732928A Ophthalmic preparation of fluconazole and method for preparing the same |
| 02/15/2006 | CN1732908A Borneol contained spray |
| 02/15/2006 | CN1241912C Disulfide derivatives useful for treating allergic diseases |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/15/2006 | CN1241569C Novel combination of non sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjuncitivitis |
| 02/15/2006 | CN1241564C Medicine having antivirus action |
| 02/15/2006 | CN1241563C Application of Jigansan extract in preparation of medicine for treating angiocardiopathy |
| 02/14/2006 | US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | CA2450740C Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/14/2006 | CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
| 02/14/2006 | CA2363145C Oxamic acids and derivatives as thyroid receptor ligands |
| 02/14/2006 | CA2269072C Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/09/2006 | WO2006014780A2 Methods and compositions for treating or preventing macular-degeneration related disorders |
| 02/09/2006 | WO2006013948A1 Triazole derivative |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060031946 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030606 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
| 02/09/2006 | US20060030604 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 02/09/2006 | US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
| 02/09/2006 | US20060030548 Methods of using ryanodine antagonists in treating neural injury |
| 02/09/2006 | US20060029684 Synergistic treatment of DNA viral infections |
| 02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
| 02/09/2006 | CA2575204A1 Methods of treating ophthalmic conditions |
| 02/08/2006 | EP1623984A1 Polymorphic form I of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/08/2006 | EP1623722A1 Composition for ophthalmic use |
| 02/08/2006 | EP1623707A1 Medicinal composition for treating sudden deafness |
| 02/08/2006 | EP1622589A1 Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
| 02/08/2006 | EP1455750B1 Viscoelastic ophthalmic compositions comprising hyaluronic acid and chondroitin sulphate |
| 02/08/2006 | EP1337262A4 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 02/08/2006 | EP1331902A4 Improved ophthalmic and contact lens solutions containing forms of vitamin b |
| 02/08/2006 | EP1187815B1 4-phenyl-pyrimidine derivatives |
| 02/08/2006 | CN1732182A Peptides and medicinal compositions containing the same |
| 02/08/2006 | CN1732008A Use of rimexolone in the treatment of dry eye |
| 02/08/2006 | CN1730081A Medicine for treating cataract and process for preparing the same |
| 02/08/2006 | CN1730014A Novel drug administration route of semen armeniacae amarum injection, its preparation process and new indications |
| 02/08/2006 | CN1729981A Pharmaceutical composition containing tetrandrine for preventing and treating corneal opacity |
| 02/08/2006 | CN1240836C Transforming growth factor alpha HI |
| 02/08/2006 | CN1240688C Quinazoline compounds |
| 02/08/2006 | CN1240681C Nitrile derivatives as cathepsin K inhibitors |
| 02/07/2006 | US6995272 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/07/2006 | US6995186 For therapy of allergic or inflammatory disorders of the eye and nose |
| 02/07/2006 | US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/07/2006 | US6995182 1-sulfonyl pyrrolidine derivatives |
| 02/07/2006 | US6995171 Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents |
| 02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
| 02/07/2006 | US6995144 for example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 02/07/2006 | US6995139 Cyclic undecapeptide pro-drugs and uses thereof |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/07/2006 | CA2311344C 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 02/07/2006 | CA2119783C Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
| 02/02/2006 | WO2006011669A1 Novel cinnamic acid related compounds |
| 02/02/2006 | WO2005051413A3 Disease associated genes |